With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...
Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...
3don MSN
The Indian Health Service Is Flagging Vaccine-Related Speech. Doctors Say They’re Being Censored.
Officials have deemed terms like “immunizations” and “vaccines” risky “buzzwords” that require approval to be used in social ...
COVID-19 cases continue to climb week-over-week as summer draws to a close, according to U.S. health data. Some regions of the United States are experiencing higher rates of positive COVID-19 tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback